What is Franklin by QIAGEN?
Franklin by QIAGEN operates at the vanguard of the bioinformatics sector, providing a robust platform that empowers clinicians, genetic counselors, and healthcare organizations to derive actionable insights from genomic data. By leveraging community-driven intelligence and advanced computational tools, the company facilitates impactful discoveries that directly influence patient outcomes. Its market position is characterized by a global reach, spanning the United States, Europe, Australia, Asia, and Latin America, where it serves as a vital link between raw genetic information and clinical decision-making processes.
How much funding has Franklin by QIAGEN raised?
Franklin by QIAGEN has raised a total of $14M across 2 funding rounds:
Series A
$6M
Unspecified
$8M
Series A (2017): $6M with participation from Glilot Capital Partners and Inimiti
Unspecified (2021): $8M led by IN Venture
Key Investors in Franklin by QIAGEN
Glilot Capital Partners
Glilot Capital is a top-performing venture capital firm focused on supporting founders in the cybersecurity and AI sectors, providing a comprehensive framework that assists companies from seed stage to market leadership.
Inimiti
Inimiti specializes in link building and search engine optimization services, aimed at helping businesses improve their online authority through premium guest posting and effective outreach.
IN Venture
IN Venture is a strategic investment firm that focuses on identifying and backing high-growth technology companies, providing the necessary capital to scale operations and market reach.
What's next for Franklin by QIAGEN?
With the recent infusion of capital, Franklin by QIAGEN is well-positioned to accelerate its enterprise-level expansion. The strategic focus will likely center on deepening the integration of its platform within existing health systems and enhancing the scalability of its genomic analysis tools. As the demand for precision medicine continues to rise, the company is expected to prioritize the development of new features that streamline diagnostic workflows and improve the interoperability of genetic data across diverse clinical environments. This phase of growth will be critical in maintaining its competitive edge in an increasingly data-centric healthcare market.
See full Franklin by QIAGEN company page
